in awake neurosurgical patients. J Neurosurg
Anesthesiol 16:156–159
16. Seehanam W, Pianthong K, Sittiwong W, Milton B (2014) Injection pressure and velocity of
impact-driven liquid jets. Eng Comput
31:1130–1150
17. Klareskog L, Tjernlund UM, Forsum U, Peterson PA (1977) Epidermal Langerhans cells
express ia antigens. Nature 268:249–250
18. Stingl G, Wolffschreiner EC, Pichler WJ,
Gschnait F, Knapp W, Wolff K (1977) Epidermal Langerhans cells bear Fc and C3 receptors.
Nature 268:245–246
19. Weissmueller NT, Marsay L, Schiffter HA, Carlisle RC, Rollier CS, Prud’homme RK, Pollard
AJ (2017) Alternative vaccine administration
by powder injection: needle-free dermal delivery of the glycoconjugate meningococcal
group Y vaccine. PLoS One 12:e0183427
20. Ismagul A, Yang N, Maltseva E, Iskakova G,
Mazonka I, Skiba Y, Bi H, Eliby S, Jatayev S,
Shavrukov Y, Borisjuk N, Langridge P (2018)
A biolistic method for high-throughput production of transgenic wheat plants with single
gene insertions. BMC Plant Biol 18:135
21. Aravindaram K, Yang NS (2009) Gene gun
delivery systems for cancer vaccine approaches.
Methods Mol Biol 542:167–178
22. Kendall M, Rishworth S, Carter F, Mitchell T
(2004) Effects of relative humidity and ambient temperature on the ballistic delivery of
micro-particles to excised porcine skin. J Invest
Dermatol 122:739–746
23. Bailey PL, Streisand JB, Pace NL, Bubbers SJ,
East KA, Mulder S, Stanley TH (1990) Transdermal scopolamine reduces nausea and vomiting
after
outpatient
laparoscopy.
Anesthesiology 72:977–980
24. Lofquist JM, Weimert NA, Hayney MS (2003)
Smallpox: a review of clinical disease and vaccination. Am J Health Syst Pharm 60:749–756;
quiz 757–758
25. Belongia EA, Naleway AL (2003) Smallpox
vaccine: the good, the bad, and the ugly. Clin
Med Res 1:87–92
26. Huang CM (2007) Topical vaccination: the
skin as a unique portal to adaptive immune
responses. Semin Immunopathol 29:71–80
27. Cope RB, Colditz IG (2000) Effect on systemic antibody concentrations of topical application of choleratoxin to skin of sheep. Aust
Vet J 78:121–123
28. Price GA, McFann K, Holmes RK (2013)
Immunization with cholera toxin B subunit
induces high-level protection in the suckling
mouse model of cholera. PLoS One 8:e57269
29. Eriksson K, Fredriksson M, Nordstrom I,
Holmgren J (2003) Cholera toxin and its B
subunit promote dendritic cell vaccination
with different influences on Th1 and Th2
development. Infect Immun 71:1740–1747
30. Kim YC, Prausnitz MR (2011) Enabling skin
vaccination using new delivery technologies.
Drug Deliv Transl Res 1:7–12
31. Gupta PN, Mishra V, Singh P, Rawat A,
Dubey P, Mahor S, Vyas SP (2005) Tetanus
toxoid-loaded transfersomes for topical immunization. J Pharm Pharmacol 57:295–301
32. Zhao Z, Wakita T, Yasui K (2003) Inoculation
of plasmids encoding Japanese encephalitis
virus PrM-E proteins with colloidal gold elicits
a protective immune response in BALB/c
mice. J Virol 77:4248–4260
33. Lim JY, Park SH, Jeong CH, Oh JH, Kim SM,
Ryu CH, Park SA, Ahn JG, Oh W, Jeun SS,
Chang JW (2010) Microporation is a valuable
transfection method for efficient gene delivery
into human umbilical cord blood-derived mesenchymal stem cells. BMC Biotechnol 10:38
34. Bramson J, Dayball K, Evelegh C, Wan YH,
Page D, Smith A (2003) Enabling topical
immunization via microporation: a novel
method for pain-free and needle-free delivery
of adenovirus-based vaccines. Gene Ther
10:251–260
35. Raphael AP, Crichton ML, Falconer RJ,
Meliga S, Chen XF, Fernando GJP, Huang H,
Kendall MAF (2016) Formulations for microprojection/microneedle vaccine delivery:
structure, strength and release profiles. J Control Release 225:40–52
36. Kwilas S, Kishimori JM, Josleyn M, Jerke K,
Ballantyne J, Royals M, Hooper JW (2014) A
hantavirus pulmonary syndrome (HPS) DNA
vaccine delivered using a spring-powered jet
injector elicits a potent neutralizing antibody
response in rabbits and nonhuman primates.
Curr Gene Ther 14:200–210
37. Matriano JA, Cormier M, Johnson J, Young
WA, Buttery M, Nyam K, Daddona PE
(2002) Macroflux (R) microprojection array
patch technology: a new and efficient approach
for intracutaneous immunization. Pharm Res
19:63–70
38. Arora A, Prausnitz MR, Mitragotri S (2008)
Micro-scale devices for transdermal drug delivery. Int J Pharm 364:227–236
39. Mikszta JA, Dekker JP, Harvey NG, Dean CH,
Brittingham JM, Huang J, Sullivan VJ, Dyas B,
Roy CJ, Ulrich RG (2006) Microneedle-based
intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect Immun
74:6806–6810
446
Akshay Datey et al.
Anesthesiol 16:156–159
16. Seehanam W, Pianthong K, Sittiwong W, Milton B (2014) Injection pressure and velocity of
impact-driven liquid jets. Eng Comput
31:1130–1150
17. Klareskog L, Tjernlund UM, Forsum U, Peterson PA (1977) Epidermal Langerhans cells
express ia antigens. Nature 268:249–250
18. Stingl G, Wolffschreiner EC, Pichler WJ,
Gschnait F, Knapp W, Wolff K (1977) Epidermal Langerhans cells bear Fc and C3 receptors.
Nature 268:245–246
19. Weissmueller NT, Marsay L, Schiffter HA, Carlisle RC, Rollier CS, Prud’homme RK, Pollard
AJ (2017) Alternative vaccine administration
by powder injection: needle-free dermal delivery of the glycoconjugate meningococcal
group Y vaccine. PLoS One 12:e0183427
20. Ismagul A, Yang N, Maltseva E, Iskakova G,
Mazonka I, Skiba Y, Bi H, Eliby S, Jatayev S,
Shavrukov Y, Borisjuk N, Langridge P (2018)
A biolistic method for high-throughput production of transgenic wheat plants with single
gene insertions. BMC Plant Biol 18:135
21. Aravindaram K, Yang NS (2009) Gene gun
delivery systems for cancer vaccine approaches.
Methods Mol Biol 542:167–178
22. Kendall M, Rishworth S, Carter F, Mitchell T
(2004) Effects of relative humidity and ambient temperature on the ballistic delivery of
micro-particles to excised porcine skin. J Invest
Dermatol 122:739–746
23. Bailey PL, Streisand JB, Pace NL, Bubbers SJ,
East KA, Mulder S, Stanley TH (1990) Transdermal scopolamine reduces nausea and vomiting
after
outpatient
laparoscopy.
Anesthesiology 72:977–980
24. Lofquist JM, Weimert NA, Hayney MS (2003)
Smallpox: a review of clinical disease and vaccination. Am J Health Syst Pharm 60:749–756;
quiz 757–758
25. Belongia EA, Naleway AL (2003) Smallpox
vaccine: the good, the bad, and the ugly. Clin
Med Res 1:87–92
26. Huang CM (2007) Topical vaccination: the
skin as a unique portal to adaptive immune
responses. Semin Immunopathol 29:71–80
27. Cope RB, Colditz IG (2000) Effect on systemic antibody concentrations of topical application of choleratoxin to skin of sheep. Aust
Vet J 78:121–123
28. Price GA, McFann K, Holmes RK (2013)
Immunization with cholera toxin B subunit
induces high-level protection in the suckling
mouse model of cholera. PLoS One 8:e57269
29. Eriksson K, Fredriksson M, Nordstrom I,
Holmgren J (2003) Cholera toxin and its B
subunit promote dendritic cell vaccination
with different influences on Th1 and Th2
development. Infect Immun 71:1740–1747
30. Kim YC, Prausnitz MR (2011) Enabling skin
vaccination using new delivery technologies.
Drug Deliv Transl Res 1:7–12
31. Gupta PN, Mishra V, Singh P, Rawat A,
Dubey P, Mahor S, Vyas SP (2005) Tetanus
toxoid-loaded transfersomes for topical immunization. J Pharm Pharmacol 57:295–301
32. Zhao Z, Wakita T, Yasui K (2003) Inoculation
of plasmids encoding Japanese encephalitis
virus PrM-E proteins with colloidal gold elicits
a protective immune response in BALB/c
mice. J Virol 77:4248–4260
33. Lim JY, Park SH, Jeong CH, Oh JH, Kim SM,
Ryu CH, Park SA, Ahn JG, Oh W, Jeun SS,
Chang JW (2010) Microporation is a valuable
transfection method for efficient gene delivery
into human umbilical cord blood-derived mesenchymal stem cells. BMC Biotechnol 10:38
34. Bramson J, Dayball K, Evelegh C, Wan YH,
Page D, Smith A (2003) Enabling topical
immunization via microporation: a novel
method for pain-free and needle-free delivery
of adenovirus-based vaccines. Gene Ther
10:251–260
35. Raphael AP, Crichton ML, Falconer RJ,
Meliga S, Chen XF, Fernando GJP, Huang H,
Kendall MAF (2016) Formulations for microprojection/microneedle vaccine delivery:
structure, strength and release profiles. J Control Release 225:40–52
36. Kwilas S, Kishimori JM, Josleyn M, Jerke K,
Ballantyne J, Royals M, Hooper JW (2014) A
hantavirus pulmonary syndrome (HPS) DNA
vaccine delivered using a spring-powered jet
injector elicits a potent neutralizing antibody
response in rabbits and nonhuman primates.
Curr Gene Ther 14:200–210
37. Matriano JA, Cormier M, Johnson J, Young
WA, Buttery M, Nyam K, Daddona PE
(2002) Macroflux (R) microprojection array
patch technology: a new and efficient approach
for intracutaneous immunization. Pharm Res
19:63–70
38. Arora A, Prausnitz MR, Mitragotri S (2008)
Micro-scale devices for transdermal drug delivery. Int J Pharm 364:227–236
39. Mikszta JA, Dekker JP, Harvey NG, Dean CH,
Brittingham JM, Huang J, Sullivan VJ, Dyas B,
Roy CJ, Ulrich RG (2006) Microneedle-based
intradermal delivery of the anthrax recombinant protective antigen vaccine. Infect Immun
74:6806–6810
446
Akshay Datey et al.